CClinicalTrials.gg
Status unknownNCT04749199Updated Feb 15, 2021

Enhanced Mirror Therapy for Improving Brain Reorganization and Function in Stroke

An interventional study of Enhanced mirror therapy and Standard mirror therapy in Stroke, sponsored by The Hong Kong Polytechnic University. Status unknown. Open to participants aged 40 Years to 75 Years. Per ClinicalTrials.gov, last updated 2021-02-15.

Sponsored by The Hong Kong Polytechnic University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Feb 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
40 Years to 75 Years
Sex
All
01

Study summary

This research aims to test the methodological procedures and obtain preliminary results regarding the therapeutic and cost-effectiveness of enhanced mirror therapy relative to standard mirror therapy for improving brain reorganization and upper limb function in individuals with stroke.

Read the detailed description

Stroke is among the leading causes of mortality and disability, worldwide. Muscle weakness and other complications associated with stroke can result in decreased quality of life and significant declines in the activities of daily living. Mirror therapy has been shown to have a moderate effect, facilitating the functional recovery among individuals who have experienced a stroke. A prototype for a computerized, mirror therapy device was developed and found to be feasible. Recently, the investigators published a critical review and an activation likelihood estimation (ALE) meta-analysis analysing the widespread reports of brain activity associated with mirror therapy. Observations using functional near-infrared spectroscopy (fNIRS) to evaluate a group of people with stroke (n = 14) and healthy volunteers (n = 18) revealed that performing complex tasks during the mirror therapy paradigm enhanced top-down motor facilitation in the ipsilesional/ipsilateral hemisphere relative to the moving limb. An important next step in this series of studies is to evaluate the training effects associated with the performance of complex tasks during mirror therapy among stroke patients, using the designed computerized mirror therapy device to deliver the enhanced mirror therapy training. The results of this study will help the investigators to understand the underlying mechanisms through which mirror therapy facilitates motor rehabilitation and will add to the body of literature describing the best, evidence-based practices for mirror therapy during stroke rehabilitation. The investigators propose a pilot study (n = 30) to test the methodological procedures and obtain preliminary results for a fully powered, randomized, controlled trial (RCT), combined with economic evaluation, to compare the therapeutic and cost-effectiveness between standard mirror therapy and enhanced (complex task and blurred image) mirror therapy.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Mirror therapy
  • Stroke
  • Hand function
  • Cost-effectiveness
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's planned enrollment of 30 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

The Hong Kong Polytechnic University is the lead sponsor of 659 studies on the registry; 250 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • adults with stroke (40-75 years old), with normal or corrected-to-normal vision and hearing;
  • post-stroke duration of ≥ 6 months, before the start of data collection;
  • no severe deficits in memory, communication, or the ability to understand verbal instructions.

Exclusion criteria

Exclusion Criteria:

  • participants with recurrent stroke; and
  • those who score \< 24 on the Mini-Mental State Examination (MMSE).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Enhanced mirror therapy group

    Participants in this group will perform complex and randomized finger opposition and reposition movements based on the training protocol, along with enhanced complexity and altered clarity of the displayed image.

    Behavioral: Enhanced mirror therapy

  • Sham comparator
    Standard mirror therapy group

    Participants in this group will perform simple and sequential finger opposition and reposition movements, along with a clear image showing the exercising hand of the participants.

    Behavioral: Standard mirror therapy

Interventions

  • BehavioralEnhanced mirror therapy

    Participants of the enhanced mirror therapy group will perform complex, randomized, finger opposition and reposition movements, using the thumb, index, middle, ring, and little fingers, and will be shown a 35% blurred visual feedback through the computerized mirror therapy device. Each participant will receive a mirror training session for 60 minutes each day, three times per week for four consecutive weeks.

    Also known as: Complex task mirror therapy

  • BehavioralStandard mirror therapy

    Participants allocated to this group will perform simple, sequential finger opposition and reposition movements, using the thumb, index, middle, ring, and little fingers, and will be shown a clear image of the exercising hand. Each participant will receive a mirror training session for 60 minutes each day, three times per week for four consecutive weeks.

    Also known as: Simple task mirror therapy

06

What researchers measure

Primary outcomes

  1. Blood oxygenated haemoglobin concentrations

    Functional near-infrared spectroscopy (fNIRS) will be used to assess neurovascular changes (blood oxygenated haemoglobin concentrations) in the M1. Higher the score obtained indicate better facilitation of the primary motor cortex.

    Time frame: Change in score at the end of 4-weeks of intervention (T1), and six months post-intervention (T2)

Secondary outcomes

  1. Wrist and hand function

    The Fugl-Meyer assessment (wrist and hand subcomponents) for the assessment of the upper limb function. The scale has a maximum score of 66 and a minimum of 34 with higher the score obtained better the wrist and hand function.

    Time frame: Change in score at the end of 4-weeks of intervention (T1), and six months post-intervention (T2)

  2. Upper limb function

    The Action Research Arm Test (ARAT), to assess upper-limb function. The ARAT scores range from 0-57, with a maximum score of 57 points indicating better performance of the upper limb.

    Time frame: Change in score at the end of 4-weeks of intervention (T1), and six months post-intervention (T2)

  3. Economic evaluation

    The Euro quality of life (EuroQol, 5 dimensions and 5 levels 62) survey, will assess the quality-adjusted life years (QALY) for the cost-effectiveness estimation. The EQ-5D-5L response will be converted into utility scores, which will be used to estimate gains or losses in quality-adjusted life-years (QALYs) over the follow-up period. The higher the score obtained better the quality-life-adjusted-years due to the intervention.

    Time frame: Change in score at the end of 4-weeks of intervention (T1), and six months post-intervention (T2)

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 15, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04749199
Lead sponsor
The Hong Kong Polytechnic University
Collaborators
University of Canterbury, National University of Singapore
Responsible party
Stanley John Winser (Assistant Professor, The Hong Kong Polytechnic University) — Principal investigator
First posted
Feb 11, 2021
Start date
May 1, 2021 (estimated)
Primary completion
Dec 1, 2021 (estimated)
Completion
Nov 1, 2022 (estimated)
Last update
Feb 15, 2021

Study contacts

Stanley John Winser
Contact
stanley.j.winser@polyu.edu.hk
27666746
Stanley John Winser
principal investigator · Hong Kong Polytechnic University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion